Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: relationship to receptor distribution

International Journal of Cancer. Journal International Du Cancer
Gillian M TozerK M Bell

Abstract

Angiotensin II (ATII) has potential for improving delivery of blood-borne anti-cancer agents to tumours by increasing tumour blood flow. However, ATII-induced hypertension is not always accompanied by an increase in tumour blood flow due to significant constriction of the tumour vasculature. Such unpredictability in tumour response to ATII limits the clinical usefulness of this approach. In this study, the potential of assessing numbers of binding sites for ATII as a predictor of tumour blood flow response to intravenous administration of ATII was investigated. The distribution of ATII receptors in the rat P22 carcinosarcoma was related to tumour blood flow distribution and blood flow response to ATII using an autoradiographic approach. ATII (0.2 microgram x kg-1 x min-1) increased mean arterial blood pressure of anaesthetized BD9 rats from 92.2 +/- 1.4 mmHG to 145.6+- 1.3 mmHg. Despite this increase in perfusion pressure, overall tumour blood flow to viable regions decreased by 20%, indicating significant constriction of tumour blood vessels. Autoradiographic localisation of tumour blood flow showed that the decrease in flow was confined to the tumour periphery, with no change at the tumour centre. This pattern was consistent ...Continue Reading

References

Jun 1, 1992·American Journal of Hypertension·P B TimmermansR D Smith
Nov 1, 1991·Japanese Journal of Cancer Research : Gann·K HoriQ H Zhang
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J TrotterP L Olive
Feb 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G M Tozer, C C Morris
Oct 1, 1985·The British Journal of Dermatology·H TakematsuT Kato
Feb 10, 1984·European Journal of Pharmacology·D R GehlertJ K Wamsley
Oct 31, 1994·Brain Research·L P ReaganS J Fluharty
Dec 1, 1994·British Journal of Cancer·G M TozerV J Cunningham
Jan 1, 1994·Advances in Experimental Medicine and Biology·G M TozerD G Hirst
Jan 1, 1993·Molecular and Chemical Neuropathology·L I ChenR N Ré
May 1, 1993·British Journal of Cancer·G M Tozer, K M Shaffi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.